Financial Gravity Asset Management’s GSK GSK Stock Holding History

Financial Gravity Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-23	Closed	-$996	–	1585
2024 Q1	$996	Buy	23 +1	+5%	+$41	﹤0.01%	740
2023 Q4	$847	Buy	+22	New	+$790	﹤0.01%	810
2021 Q3	–	Hold	0	–	–	–	652
2021 Q2	–	Hold	0	–	–	–	636
2020 Q4	$2K	Buy	+45	New	+$2.07K	﹤0.01%	319
2019 Q4	$72K	Sell	650 -8	-1%	-$445	0.05%	462
2019 Q3	$35K	Buy	658 +19	+3%	+$977	0.03%	349
2019 Q2	$32K	Buy	639 +246	+63%	+$12.3K	0.03%	401
2019 Q1	$21K	Buy	+393	New	+$19.6K	0.02%	432
2018 Q3	$23K	Buy	476 +206	+76%	+$10.5K	0.02%	454
2018 Q2	$14K	Buy	270 +7	+3%	+$353	0.01%	519
2018 Q1	$13K	Buy	+263	New	+$12.2K	0.01%	550

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Financial Gravity Asset Management's GSK Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of GSK (GSK) in Q2 2024, closing a stake of 23 shares — an estimated $996 sold.

Financial Gravity Asset Management first reported a position in GSK in Q1 2018 and held it in 10 quarters. The position peaked at $72K in Q4 2019. 885 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

Financial Gravity Asset Management reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
Financial Gravity Asset Management sold 23 GSK shares in Q2 2024, an estimated $996.
Financial Gravity Asset Management first reported a position in GSK in Q1 2018 and held it in 10 quarters.
Financial Gravity Asset Management's GSK position peaked at $72K in Q4 2019.
885 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.